Evidence map›Paper›PMID 28762473›Full record

ArticleDevelopmental medicine and child neurology2017

Late diagnosis and atypical brain imaging of Aicardi-Goutières syndrome: are we failing to diagnose Aicardi-Goutières syndrome-2?

Leah Svingen, Mitchell Goheen, Rena Godfrey, Colleen Wahl, Eva H Baker, William A Gahl, May Christine V Malicdan, Camilo Toro

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Developmental medicine and child neurology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Nucleotide metabolism, leukodystrophies, and CNS pathology.Journal of inherited metabolic disease · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Leah SvingenNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
Mitchell GoheenNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
Rena GodfreyNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
Colleen WahlNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
Eva H BakerDiagnostic Radiology Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, MD, USA.
William A GahlNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
May Christine V MalicdanNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.ORCID 0000-0003-1697-6959
Camilo ToroNIH Undiagnosed Diseases Program, Common Fund, Office of the Director, Bethesda, MD, USA.
Office of the Director · USNational Institutes of Health · USNational Institutes of Health Clinical Center · US

Funding

Intramural NIH HHS Z99 HG999999
6 · The paper itself

Abstract

Aicardi-Goutières syndrome (AGS) is a rare disorder with in utero or postnatal onset of encephalopathy and progressive neurological deterioration. The seven genetic subtypes of AGS are associated with abnormal type I interferon-mediated innate immune response. Most patients with AGS present with progressive microcephaly, spasticity, and cognitive impairment. Some, especially those with type 2 (AGS2), manifest milder phenotypes, reduced childhood mortality, and relative preservation of physical and cognitive abilities. In this report, we describe two siblings (sister and brother) diagnosed with AGS2 in their second decade, who exhibited static encephalopathy since 1 year of age with spastic quadriplegia and anarthria but preserved intellect. Both were homozygous for the common pathogenic RNASEH2B allele (c.529G>A, p.Ala177Thr). Rather than manifesting calcifications and leukoencephalopathy, both had increased iron signal in the basal ganglia. Our report broadens the clinical and imaging spectrum of AGS2 and emphasizes the importance of including AGS2 in the differential diagnosis of idiopathic spastic cerebral palsy. WHAT THIS PAPER ADDS: We identified two siblings (sister and brother) with atypical Aicardi-Goutières syndrome type 2 due to RNASEH2B mutation. Manifestations included spastic quadriplegia and anarthria but preserved intellect and increased iron signal in the basal ganglia. RNASEH2B-related Aicardi-Goutières syndrome type 2 can have present with a variable phenotype, including idiopathic spastic cerebral palsy.

Indexed as

AdolescentAutoimmune Diseases of the Nervous SystemDelayed DiagnosisDysarthriaFemaleHumansMaleNervous System MalformationsQuadriplegiaRibonuclease HRibonuclease Hribonuclease HII

Identifiers

PMID28762473
PMCPMC5685901
OpenAlexW2741043350

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.